Literature DB >> 28837400

PKC SUMOylation inhibits the binding of 14-3-3τ to GluK2.

Xiaoling Li1,2, Yan Wang1,3, Aoxue Zhu1, Jie Zhou1, Yong Li1.   

Abstract

Phosphorylation and SUMOylation of the kainate receptor (KAR) subunit GluK2 have been shown to regulate KAR surface expression, trafficking and synaptic plasticity. In addition, our previous study has shown that a phosphorylation-dependent interaction of 14-3-3τ and GluK2a-containing receptors contributes to the slow decay kinetics of native KAR-EPSCs. However, it is unknown whether SUMOylation participates in the regulation of the interaction between 14-3-3τ and GluK2a-containing receptors. Here we report that SUMOylation of PKC, but not GluK2, represses the binding of 14-3-3τ to GluK2a via decreasing the phosphorylation level of GluK2a. These results suggest that PKC SUMOylation is an important regulator of the 14-3-3 and GluK2a protein complex and may contribute to regulate the decay kinetics of KAR-EPSCs.

Entities:  

Keywords:  14–3–3τ; GluK2; PKC SUMOylation; phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28837400      PMCID: PMC5786187          DOI: 10.1080/19336950.2017.1370525

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  31 in total

1.  Kainate receptor-mediated presynaptic inhibition at the mouse hippocampal mossy fibre synapse.

Authors:  H Kamiya; S Ozawa
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

2.  Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses.

Authors:  D Schmitz; J Mellor; R A Nicoll
Journal:  Science       Date:  2001-02-08       Impact factor: 47.728

Review 3.  Molecular physiology of kainate receptors.

Authors:  J Lerma; A V Paternain; A Rodríguez-Moreno; J C López-García
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

Review 4.  Kainate receptor trafficking: physiological roles and molecular mechanisms.

Authors:  John T R Isaac; Jack Mellor; David Hurtado; Katherine W Roche
Journal:  Pharmacol Ther       Date:  2004-12       Impact factor: 12.310

5.  C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.

Authors:  Stephanie Carter; Oliver Bischof; Anne Dejean; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2007-03-18       Impact factor: 28.824

6.  PKC-dependent autoregulation of membrane kainate receptors.

Authors:  Rocío Rivera; José Luis Rozas; Juan Lerma
Journal:  EMBO J       Date:  2007-09-27       Impact factor: 11.598

7.  Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death.

Authors:  Yitao Qi; Jingxiong Wang; Valerie C Bomben; De-Pei Li; Shao-Rui Chen; Hao Sun; Yutao Xi; John G Reed; Jinke Cheng; Hui-Lin Pan; Jeffrey L Noebels; Edward T H Yeh
Journal:  Neuron       Date:  2014-09-03       Impact factor: 17.173

8.  Sequential posttranslational modifications program FEN1 degradation during cell-cycle progression.

Authors:  Zhigang Guo; Julie Kanjanapangka; Na Liu; Songbai Liu; Changwei Liu; Zhenxing Wu; Yingjie Wang; Tiffany Loh; Claudia Kowolik; Joonas Jamsen; Mian Zhou; Khue Truong; Yuan Chen; Li Zheng; Binghui Shen
Journal:  Mol Cell       Date:  2012-06-30       Impact factor: 17.970

9.  CaMKII-dependent phosphorylation of GluK5 mediates plasticity of kainate receptors.

Authors:  Mario Carta; Patrizio Opazo; Julien Veran; Axel Athané; Daniel Choquet; Françoise Coussen; Christophe Mulle
Journal:  EMBO J       Date:  2013-01-04       Impact factor: 11.598

10.  SUMO-specific protease 1 protects neurons from apoptotic death during transient brain ischemia/reperfusion.

Authors:  Huijun Zhang; Yan Wang; Aoxue Zhu; Dehua Huang; Shining Deng; Jinke Cheng; Michael X Zhu; Yong Li
Journal:  Cell Death Dis       Date:  2016-11-24       Impact factor: 8.469

View more
  1 in total

Review 1.  SUMOylation of synaptic and synapse-associated proteins: An update.

Authors:  Jeremy M Henley; Richard Seager; Yasuko Nakamura; Karolina Talandyte; Jithin Nair; Kevin A Wilkinson
Journal:  J Neurochem       Date:  2020-07-05       Impact factor: 5.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.